These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36980627)
41. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Patterson DM; Murugaesu N; Holden L; Seckl MJ; Rustin GJ Int J Gynecol Cancer; 2008; 18(1):43-50. PubMed ID: 17466047 [TBL] [Abstract][Full Text] [Related]
42. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Chen H; Xiao L; Li J; Cui L; Huang W Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035 [TBL] [Abstract][Full Text] [Related]
43. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort. Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319 [TBL] [Abstract][Full Text] [Related]
44. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621 [TBL] [Abstract][Full Text] [Related]
45. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111 [TBL] [Abstract][Full Text] [Related]
46. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis. Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361 [TBL] [Abstract][Full Text] [Related]
47. Recent management of malignant ovarian germ cell tumors: a study of 34 cases. Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325 [TBL] [Abstract][Full Text] [Related]
48. Surgery for germ cell tumors. Sagae S; Kudo R Semin Surg Oncol; 2000; 19(1):76-81. PubMed ID: 10883028 [TBL] [Abstract][Full Text] [Related]
49. Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma. AlHilli M; Amarnath S; Elson P; Rybicki L; Dowdy S Int J Gynecol Cancer; 2020 Jun; 30(6):789-796. PubMed ID: 32184268 [TBL] [Abstract][Full Text] [Related]
50. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery]. Schröder W Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476 [TBL] [Abstract][Full Text] [Related]
51. Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit. Richardson MT; Mysona DP; Klein DA; Mann A; Liao CI; Diver EJ; Darcy KM; Tian C; She JX; Ghamande S; Van Le L; Kapp DS; Chan JK Gynecol Oncol; 2020 Oct; 159(1):118-128. PubMed ID: 32828578 [TBL] [Abstract][Full Text] [Related]
52. Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 Studies. Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Borgonovo K; Lonati V; Barni S Clin Genitourin Cancer; 2015 Oct; 13(5):428-34. PubMed ID: 25959904 [TBL] [Abstract][Full Text] [Related]
53. The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia: A meta-analysis of randomized clinical trials. Wang H; Xiao X; Xiao Q; Lu Y; Wu Y Medicine (Baltimore); 2020 Jun; 99(24):e20094. PubMed ID: 32541448 [TBL] [Abstract][Full Text] [Related]
54. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture. Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897 [TBL] [Abstract][Full Text] [Related]
55. Characteristics, diagnosis and treatment of hepatic metastasis of pure immature ovarian teratoma. Fan Q; Huang H; Lian L; Lang J Chin Med J (Engl); 2001 May; 114(5):506-9. PubMed ID: 11780414 [TBL] [Abstract][Full Text] [Related]
56. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Dickinson HO Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360 [TBL] [Abstract][Full Text] [Related]
57. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926 [TBL] [Abstract][Full Text] [Related]
58. A systematic overview of chemotherapy effects in ovarian cancer. Högberg T; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940 [TBL] [Abstract][Full Text] [Related]
59. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Dickinson HO Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239 [TBL] [Abstract][Full Text] [Related]
60. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]